体外循环与否对冠脉搭桥术后新发癌症长期风险的影响
多因素Cox回归与倾向评分匹配分析均显示,体外循环与术后新发癌症风险及癌症特异性死亡风险无显著关联。
要点
- 冠脉搭桥术中使用体外循环未增加新发癌症风险(校正HR 0.95,95%CI 0.90-1.01)。
- 体外循环与癌症特异性死亡风险亦无显著关联(校正HR 0.99,95%CI 0.89-1.09)。
- 倾向评分匹配3735对结果一致,支持体外循环不增加癌症风险的结论。
核心结论
- 冠脉搭桥术中使用体外循环与术后新发癌症风险及癌症特异性死亡风险升高无关。
研究设计与样本
- 数据来自SWEDEHEART注册库及另外4个强制性国家注册库的个体患者数据合并。
- 采用多因素Cox比例风险回归(校正基线特征、合并症、社会经济因素及手术时间),并行3735对倾向评分匹配分析。
主要发现
- 体外循环组与非体外循环组粗事件率分别为2.71与2.68每100人年。
- 校正后癌症风险HR 0.95(95%CI 0.90-1.01),癌症特异性死亡HR 0.99(95%CI 0.89-1.09)。
- 倾向评分匹配分析结果相似:HR 0.96(95%CI 0.89-1.04)与0.99(95%CI 0.85-1.13)。
临床怎么用
- 冠脉搭桥决策时,体外循环相关的远期癌症风险不应作为术式选择的顾虑因素。
局限性
- 原文摘要未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: It has been suggested that long-term risk for incident cancer is increased in patients operated with cardiopulmonary bypass. We compared the risk for incident cancer and cancer-specific death between patients undergoing coronary artery bypass grafting (CABG) with and without cardiopulmonary bypass. METHODS: All patients without a history of cancer undergoing first-time CABG in Sweden during 1997-2020 were included in a nationwide population-based observational cohort study. Individual patient data from the SWEDEHEART registry and 4 other mandatory national registries were merged. The incidence of new cancer was compared between patients operated with or without cardiopulmonary bypass using multivariable Cox proportional hazards regression models adjusted for baseline characteristics, co-morbidities, socioeconomic factors and time of surgery. A propensity score-matched analysis with 3735 well-balanced pairs was also performed. RESULTS: A total of 81 097 patients undergoing CABG with (n = 77 345) and without cardiopulmonary bypass (n = 3752) were included. Median follow-up was 8.2 (interquartile range 4.0-13.2) years. The crude event rates were 2.71 and 2.68 per 100 person-years in the patients operated with and without cardiopulmonary bypass, respectively. There was no difference in the adjusted risk for cancer between the groups [adjusted hazard ratio 0.95 (95% confidence interval; CI 0.90-1.01)] or in the risk for cancer-specific death between the groups [adjusted hazard ratio 0.99 (95% CI 0.89-1.09)]. The propensity score-matched analysis showed similar results [hazard ratio 0.96 (95% CI 0.89-1.04) and 0.99 (95% CI 0.85-1.13)], respectively. CONCLUSIONS: Cardiopulmonary bypass is not associated with an increased risk of incident cancer or cancer-specific mortality in patients undergoing CABG.
引用
- Mennander A, Nielsen SJ, Skyttä T, et al. Long-term risk for incident cancer in patients undergoing coronary artery bypass grafting with or without cardiopulmonary bypass: a nationwide population-based study. Eur J Cardiothorac Surg. 2025. PMID: 40128151. doi:10.1093/ejcts/ezaf110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。